PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above 200 Day Moving Average – Time to Sell?

PURE Bioscience, Inc. (OTCMKTS:PURE)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.08 and traded as high as $0.08. PURE Bioscience shares last traded at $0.08, with a volume of 32,037 shares traded.

PURE Bioscience Price Performance

The firm’s 50-day moving average is $0.08 and its 200-day moving average is $0.08. The company has a market capitalization of $9.39 million, a P/E ratio of -2.10 and a beta of 0.07.

PURE Bioscience (OTCMKTS:PURE) last posted its earnings results on Monday, December 16th. The company reported ($0.01) earnings per share for the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.